Pfizer Limited has announced its audited financial results for the fiscal year ended March 31, 2026, reporting a total income of ₹2,707.60 crore and a net profit of ₹722.43 crore. The Board of Directors has recommended a final dividend of ₹75 per equity share, representing a 750% payout. The company also confirmed its upcoming 75th Annual General Meeting, scheduled to be held virtually on July 28, 2026.
Financial Performance Overview
For the financial year 2025-26, Pfizer Limited delivered a solid performance with total income reaching ₹2,707.60 crore, compared to ₹2,453.60 crore in the previous year. The company recorded a net profit of ₹722.43 crore. The financial results underscore the firm’s stability, maintaining a strong position in the pharmaceuticals segment.
Dividend and Shareholder Payout
The Board of Directors has recommended a final dividend of ₹75 per equity share of face value ₹10, amounting to a total distribution of ₹343.11 crore. Shareholders listed on the company’s register as of the record date, July 17, 2026, will be eligible for this payout, which is scheduled for on or after August 4, 2026, subject to approval at the annual meeting.
Strategic Appointments and Corporate Updates
In other developments, the company has appointed M/s. Kishore Bhatia & Associates as the new Cost Auditors for the financial year ending March 31, 2027. Furthermore, the company clarified its status, confirming it does not fall under the category of a ‘Large Corporate’ as per prevailing criteria, given its debt and borrowing profile. The 75th Annual General Meeting is set for July 28, 2026, and will be conducted through video conferencing and other audio-visual means.
Notes on Exceptional Items
The financial results reflect specific exceptional items totaling a charge of ₹49.16 crore. This includes personnel separation costs related to an exclusive supply and marketing agreement with Cipla Limited, as well as provisions resulting from adjustments to comply with the new Labour Codes implemented by the Government of India.
Source: BSE
